Vanderbilt Training Program in Academic Cancer Research

范德比尔特学术癌症研究培训计划

• 批准号: 7232823
• 负责人: DAVID H JOHNSON
• 金额: $ 13.76万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-07-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7232823
• 关键词: Training Programs; anticancer research

DESCRIPTION (provided by applicant): Progress against cancer includes our ability to provide quality cancer care and support research within clinical trials. However, there is a significant shortage of well-trained oncologists/hematologists capable of comprehensive study of clinically-relevant problems; successful design and conduct of clinical trials to improve prevention, detection and treatment of human cancer; and most importantly, the translation of fundamental knowledge and new technologies between the laboratory, clinic, and community. The development of successful, independent translational cancer investigators requires adequate protected time and a strong mentorship in a rich research environment and well organized training program. The Vanderbilt-lngram Cancer Center, a matrix center within Vanderbilt Medical Center, is well-suited to support such a comprehensive training program due to its integrated cancer-related expertise and resources. The objective of the Vanderbilt Training Program in Academic Cancer Research is to train and support medical oncology/hematology fellows to ensure their success to meet new challenges and opportunities in all aspects of academic medical oncology/hematology. Candidates will be recruited from the Division of Hematology and Oncology Fellowship Program. Applicants accepted will participate in a comprehensive two-year training program consisting of two training tracks: (1) Clinical-Investigator Track will focus on the development and conduct of clinical trials and associated correlative studies (2) Physician-Scientist Track will focus on laboratory-based research. Fellows who complete either training track will be eligible for ABIM subspecialty certification in medical oncology and hematology. Upon completion of the program, trainees will be able to successfully function in a collaborative team environment, develop and lead independent research programs through hypothesis-driven research, obtain peer-reviewed grant support, communicate their research findings through presentations and publication in peer-reviewed journals, and provide high quality cancer care. To help ensure success, 100% of the program faculty have peer-reviewed support for cancer research and are actively conducting clinical and/or laboratory-based cancer research, consistently published in the best journals, have demonstrated mentorship abilities, and actively manage successful research programs. Support is being requested for two training positions per year.

描述（由申请人提供）：针对癌症的进展包括我们在临床试验中提供优质癌症护理和支持研究的能力。但是，训练有素的肿瘤学家/血液学家缺乏能够全面研究临床上的问题。成功设计和进行临床试验，以改善人类癌症的预防，检测和治疗；最重要的是，实验室，诊所和社区之间基本知识和新技术的翻译。成功的独立转化癌症研究者的发展需要足够的保护时间，并且需要在丰富的研究环境和组织良好的培训计划中进行强有力的指导。 Vanderbilt-Lngram癌症中心是Vanderbilt医疗中心的基质中心，非常适合支持这种全面的培训计划，因为其综合癌症相关的专业知识和资源。范德比尔特学术癌症研究培训计划的目的是培训和支持医学肿瘤学/血液学研究员，以确保他们成功地应对学术医学肿瘤学/血液学各个方面的新挑战和机遇。候选人将从血液学和肿瘤学奖学金计划的部门招募。接受的申请人将参加由两种培训轨道组成的全面的为期两年的培训计划：（1）临床评估者轨道将重点关注临床试验和相关研究的开发和进行（2）医师科学家轨道将集中在基于实验室的研究上。完成任一训练轨道的研究员将有资格获得医学肿瘤学和血液学的ABIM亚科认证。该计划完成后，学员将能够在协作团队的环境中成功运作，通过假设驱动的研究制定和领导独立的研究计划，获得同行评审的赠款支持，通过在PEER评估期刊中的演讲和出版物来传达其研究结果，并提供高质量的癌症护理。为了帮助确保成功，100％的计划教师对癌症研究的同行评审支持，并且正在积极进行临床和/或实验室的癌症研究，并始终发表在最佳期刊上，已证明了指导能力，并积极管理成功的研究计划。每年都要求支持两个培训职位。